Venrock Healthcare Capital Partners acquired an aggregate 1.3M common shares of Altimmune (NASDAQ:ALT) at a weighted average price ranging from $8.40 to $9.39.

The fund now owns 3M shares of the company.

ALT +16.1% premarket.

READ FULL ARTICLE HERE